KDR and thyroiditis: CRISPR/Cas9 gene editing as well as use of RTK inhibitor sunitinib of VEGFR2/KDR significantly disrupted thyroid cell cycle regulation, cell growth, and downstream signal transduction, resulting in decreased colony formation and invasion abilities.